Corporate Partner

Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omaveloxolone) for Friedreich’s Ataxia. Learn What this Means for the Mito Community.

Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation Company to...

Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation Company to...

UMDF is proud to shine this month’s Corporate Partner Spotlight on Summit Health Pharmacy. We are grateful to Vince Canazanese, Robin...

This holiday season, we count on the generosity of corporate partners to make a difference in the lives of those affected by mitochondrial...

UMDF’s Mitochondrial Medical Symposium has become the place where news breaks on the latest potential treatments and clinical trials. In 2019,...